- Physician's Weekly

Part 2: Medicolegal Issues During the COVID-19 Pandemic

Jul 3, 2020

This three-part series—Part 1 in the June issue covered patient confidentiality—reviews a few topics giving physicians concern during the COVID-19 pandemic. Maintaining Office Safety PATIENTS l You retain the right to refuse a...

Part 2: Medicolegal Issues During the COVID-19 Pandemic

Jul 3, 2020

This three-part series—Part 1 in the June issue covered patient confidentiality—reviews a few topics giving physicians concern during the COVID-19 pandemic. Maintaining Office Safety PATIENTS l You retain the right to refuse a...

Part 2: Medicolegal Issues During the COVID-19 Pandemic

Jul 3, 2020

This three-part series—Part 1 in the June issue covered patient confidentiality—reviews a few topics giving physicians concern during the COVID-19 pandemic. Maintaining Office Safety PATIENTS l You retain the right to refuse a...

Hydroxychloroquine Cuts Mortality by 50%

Jul 2, 2020

DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System....

PART 1: Avoiding Liability in Telemedicine: Licensure & Coverage

Jul 1, 2020

Telemedicine has exploded in scope with the COVID-19 pandemic and will leave a lasting imprint on how medicine is practiced, so it is essential for physicians to understand its basic principles and the specific rules that govern...

PART 1: Avoiding Liability in Telemedicine: Licensure & Coverage

Jul 1, 2020

Telemedicine has exploded in scope with the COVID-19 pandemic and will leave a lasting imprint on how medicine is practiced, so it is essential for physicians to understand its basic principles and the specific rules that govern...

How Locum Tenens can Help You in Your Permanent Job

Jul 1, 2020

There’s a misconception that locum tenens doctors are constantly traveling across the country,...

The Importance & Power of Physicians Advocating for Themselves

Jul 1, 2020

In the past, we as physicians have not done a great job of advocacy, and we have largely been removed from policy discussions. The emergence of physician advocacy is a relatively new phenomenon. Why? … Read Full Article...

PART 1: Avoiding Liability in Telemedicine: Licensure & Coverage

Jul 1, 2020

Telemedicine has exploded in scope with the COVID-19 pandemic and will leave a lasting imprint on how medicine is practiced, so it is essential for physicians to understand its basic principles and the specific rules that govern...

PART 1: Avoiding Liability in Telemedicine: Licensure & Coverage

Jul 1, 2020

Telemedicine has exploded in scope with the COVID-19 pandemic and will leave a lasting imprint on how medicine is practiced, so it is essential for physicians to understand its basic principles and the specific rules that govern...

New Immunotherapy Treatment Promising for NSCLC

Jun 26, 2020

A new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being...

MET Mutation Inhibitor Associated with Tumor Reductions in NSCLC

Jun 26, 2020

Targeting tumor driver appears effective in half of NSCLC patients Treatment with the...

Conference Highlights: AACR 2020

Jun 25, 2020

New research was virtually presented at AACR 2020, the American Association for Cancer Research...

Comparing Approaches to Oligometastatic NSCLC Management

Jun 25, 2020

While it was previously thought that a subset of patients with limited metastatic disease could...

CASPIAN Trial Update: Phase 3 Results & Perspectives

Jun 23, 2020

Updated findings from the phase 3 CASPIAN trial presented at the 2020 American Society of Clinical...

Nivolumab and Chemo Significantly Improved Survival in ES-SCL

Jun 23, 2020

In the phase 2 ECOG-ACRIN EA5161 trial, a significant improvement in both progression-free and overall survival was observed from adding the checkpoint inhibitor nivolumab to chemotherapy (cisplatin/carboplatin with etoposide)...